Approval · Notice of Compliance 11446 · 2010
VOTRIENT: Notice of Compliance 11446
Issued May 27, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11446
- Date
- May 27, 2010
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic agent
Products in this notice
Medicinal ingredients
- PAZOPANIB HYDROCHLORIDE 200 MG per TAB
- PAZOPANIB HYDROCHLORIDE 400 MG per TAB